The role and reversibility of vascular alterations in the development, progression and regression of metabolic dysfunction-associated steatotic liver disease (MASLD)

Bron
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,259 p.

A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells

Bron
JHEP Reports - ISSN 2589-5559-8:4 (2026) p. 1-11
Auteur(s)

STRONG II trial : stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma – a single-arm multicentre phase II study

Bron
BMJ open - ISSN 2044-6055-15:7 (2025) p. 1-11
Auteur(s)
    Suus Y. van Loosbroek, Maaike T.W. Milder, Dirk de Ruysscher, Rianne D.W. Vaes, Wilhelm den Toom, François Willemssen, Ferry Eskens, Marjolein Y.V. Homs, Bas Groot Koerkamp, Lydi M.J.W van Driel, Yvette Seppenwoolde, Erik van Werkhoven, Martijn Intven, Nadia Haj Mohammad, Joep de Bruijne, Eva Versteijne, Anna M. Bruynzeel, Freek Brandts, Joris I. Erdmann, Harm Westdorp, Pètra M. Braam, Eric T.T.L. Tjwa, Christelle Bouchart, Anne Demols, Akos Gulyban, Jeroen Buijsen, Judith de Vos-Geelen, Maxime Dewulf, Ines Joye, Timon Vandamme, Luisa Vonghia, Derk Jan de Groot, Margriet Dieters, Fred J.F. Ubbels, Frederik J.H. Hoogwater, Ben Heijmen, Alejandra Méndez Romero